Hjem › Brystkreft › Arizona › Goodyear
Kliniske studier for Brystkreft i Goodyear, AZ
6 studier for Brystkreft søker deltakere på steder i og rundt Goodyear (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruttererFase 3
- Western Reg MC-COH Phoenix, Goodyear
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Ironwood Cancer & Research Centers, Goodyear
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruttererFase 3
- City of Hope - Phoenix, Goodyear
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- City of Hope - Cancer Center Phoenix, Goodyear
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Investigative Site #108, Goodyear
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Ironwood Cancer & Research Centers, Goodyear
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Goodyear
- Ikke-småcellet lungekreft8 studier
- Metastatisk kreft7 studier
- Kolorektal kreft5 studier
- Prostatakreft4 studier
- Lungekreft4 studier
- Tykktarmskreft3 studier
- Pankreaskreft3 studier
- Akut myelogen leukemi3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.